Evaluating pain during intramuscular injections in adult psychiatry
Assessment of Pain During Intramuscular Injection Delay in Adult Psychiatry
This study is testing how much pain and anxiety people feel during intramuscular injections of antipsychotic medications to find ways to make the experience easier for patients.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 393 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Centre hospitalier de Ville-Evrard, France Academic / other |
| Locations | 1 site (Neuilly-sur-Marne) |
| Trial ID | NCT04784572 on ClinicalTrials.gov |
What this trial studies
This exploratory study aims to assess the pain and anxiety experienced by patients receiving intramuscular injections of antipsychotic medications. It will evaluate how various pharmacological factors, such as the type of medication, injection frequency, and individual patient characteristics, influence the perception of pain during these injections. The goal is to develop strategies to minimize pain and anxiety, thereby improving patient compliance and reducing the likelihood of treatment relapses in the long term.
Who should consider this trial
Good fit: Ideal candidates include adults over 18 years old who are hospitalized or outpatient and prescribed antipsychotic injections.
Not a fit: Patients on long-term analgesic treatment or those with chronic pain may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved patient comfort and adherence to antipsychotic treatment.
How similar studies have performed: While the specific approach of this study may be novel, similar studies have indicated that addressing pain and anxiety can enhance treatment compliance.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients (Males, Females) * Over the age of 18 * Hospitalized or outpatient * Patient affiliated with social security, State Medical Aid (AME) * With prescription of antipsychotic delay by intramuscular injection * French language mastered * Given oral consent to pass the self-assessment scales Exclusion Criteria: * Patients on long-term analgesic treatment, daily * Patients with chronic pain with or without analgesic treatment * Patient not communicating * Pregnant woman, parturint and nursing mother * Person deprived of liberty by judicial or administrative decision * Minor and person subject to legal protection: guardianship or curatorship
Where this trial is running
Neuilly-sur-Marne
- Ch Ville Evrard — Neuilly-sur-Marne, France (Recruiting)
Study contacts
- Study coordinator: Rusheenthira THAVASEELAN, MSC
- Email: r.thavaseelan@epsve.fr
- Phone: 0143093232
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.